Dr. Marc Dietrich

Dr. Marc Dietrich, MD, currently serves as an Investment Partner at SwissHealth Ventures, focusing on digital health start-ups as part of CSS Group. Alongside this role, Marc is an Investor at deepc, which provides AI solutions for radiology, and a Board Observer for both Flow Neuroscience and Kranus Health, companies dedicated to innovative therapies for major depressive disorder and erectile dysfunction, respectively. Previously, Marc held leadership positions at various health tech companies, including CEO and Founder at finestreams AG, and Board Director roles at Apricity, Trialbee, and Mediktor. Marc's educational background includes a Doctoral Degree in Medicine and certifications in Pharmaceutical Medicine from the University of Basel and ECPM.